Article Per Year (5 Year)
p-Index From 2019 - 2024
0.444
P-Index
This Author published in this journals
All Journal Radinka Journal of Health Science
Medi ANDRIANI
Pharmacy Study Program, Sekolah Tinggi Ilmu Kesehatan Harapan Ibu, Jambi, Indonesia
Dentistry Health Professions Medicine & Pharmacology Nursing Public Health

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

 1 
Literature Review Related to Factors That Influence Adherence to Medication Use in Hypertension Patients in Primary Health Facilities Tricy Opi Zalita; Rifani Bhakti NATARI; Medi ANDRIANI
RADINKA JOURNAL OF HEALTH SCIENCE Vol. 1 No. 3 (2024): Radinka Journal of Health Science (RJHS)
Publisher : RADINKA JAYA UTAMA PUBLISHER

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Hypertension is a disease that requires long-term therapy, so patient compliance is required in undergoing treatment to control blood pressure and reduce the risk of complications. Riskesdas data (2018) shows that the prevalence of non-compliance with taking medication in hypertensive patients is 32.3%. This study aims to determine the factors that influence compliance with medication use in hypertensive patients in primary health facilities. This research is a literature review research. Selection of research articles reviewed using the PRISMA method using relevant keywords (adherence to medication use, hypertension patients, primary level health facilities, influencing factors) and based on inclusion and exclusion criteria. The research was conducted at the STIKES Harapan Ibu Jambi Library from May to June 2023. Based on the research results, it is known that the factors that influence compliance with the use of antihypertensive drugs in hypertensive patients in primary-level health facilities are age, education, employment, knowledge, attitudes, motivation, family support, role of health workers, affordability of health services, duration of therapy and comorbid (p-value e<0.05). It is hoped that community health centers will provide education about the importance of compliance with the use of antihypertensive drugs in hypertension sufferers that is easy to understand so that they are compliant in taking antihypertensive medication.
Evaluation of the Use of Antihypertension Medications in Inpatient Chronic Kidney Failure Patients at X Hospital, Jambi City, 2022 Sepriani; Medi ANDRIANI; Aisa Dinda MITRA
RADINKA JOURNAL OF HEALTH SCIENCE Vol. 1 No. 2 (2023): Radinka Journal of Health Science (RJHS)
Publisher : RADINKA JAYA UTAMA PUBLISHER

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Chronic kidney disease is a global public health problem with increasing prevalence and incidence of kidney failure, poor prognosis, and high costs. The incidence of CKD in Jambi Province was 30,554 cases. This study aims to determine the use of antihypertensive drugs in inpatient chronic kidney failure patients at Hospital X, Jambi City. This research is a descriptive study with retrospective data collection. The research sample was antihypertensive drugs used by patients with chronic kidney failure at Hospital X Jambi City for the period January to February 2022, totaling 50 prescriptions. The sampling technique is purposive sampling. The research instrument is a data collection sheet. The results of the study showed that 52.0% of the patients were female, 36.0% of the patients were in the late elderly category, the class of drugs most commonly used was Calcium Channel Blockers, namely 47.6%, the majority of respondents used a combination drug, 62.0 %. The rationality of the drugs used shows that there is a 100% correct dose, 100% correct route of administration, 100% correct duration of drug administration, and 94.0% no drug interactions. The Wilcoxon test results showed that there was an influence of the use of antihypertensive drugs on the blood pressure of CKD patients (p-value=0.000). It is hoped that doctors will choose drugs with a lower interaction profile to reduce the risk of dangerous interactions.
Co-Authors Aisa Dinda MITRA Rifani Bhakti NATARI Sepriani Tricy Opi Zalita